Aquarius Surgical Technologies (AQQRF) AI Stock Analysis
Aquarius Surgical Technologies
(Other OTC:AQQRF)
No summary available
Aquarius Surgical Technologies (AQQRF) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $115.92K
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -0.3
- Beta (1Y)
- -168.55
- Revenue Growth
- 9.11%
- EPS Growth
- -596.49%
- Country
- US
- Employees
- 3
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
Aquarius Surgical Technologies Business Overview & Revenue Model
Company Description
Aquarius Surgical Technologies Inc., operating through its subsidiary Surgical Lasers Inc., specializes in the creation, sale, distribution, and promotion of advanced technological solutions tailored for surgical and other healthcare settings through...
Aquarius Surgical Technologies Peers Comparison
Overall Rating
TSE:PRN50Neutral
TSE:ASG47Neutral
TSE:VPT46Neutral
TSE:PINK38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 50Neutral | CAD 335.37M | -6.77 | -62.45% | ― | 59.60% | 32.53% | |
| 47Neutral | CAD 8.98M | -5.36 | -34.32% | ― | -5.42% | -5.37% | |
| 46Neutral | CAD 15.43M | -6.13 | 56.40% | ― | 89.06% | 37.62% | |
| 38Underperform | CAD 27.62M | -1.41 | -303.05% | ― | 35.27% | 58.34% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AQQRF | Aquarius Surgical Technologies | 0.50 | 0.00 | 0.00% | |
| TSE:ASG | Aurora Spine | 0.12 | -0.17 | -58.93% | |
| TSE:PINK | Perimeter Medical Imaging Ai Inc | 0.18 | -0.05 | -23.40% | |
| TSE:PRN | Profound Medical | 9.18 | 0.91 | 11.00% | |
| TSE:VPT | VentriPoint Diagnostics | 0.08 | -0.02 | -20.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.